supplements that act like semaglutide Natural Ozempic Alternatives: A Full Breakdown Does 'Nature's Ozempic' Exist? What

Patients with renal impairment taking compounded semaglutide may be at a higher risk of acute kidney injury, and those without known underlying renal disease may also experience kidney-related issues

A peer-reviewed study published this past autumn estimated that about 4.7 million U.S

Seeley imagined a hypothetical patient with obesity who is diagnosed with breast cancer

Lipo C Shots- Whats the Difference

CrossRef Preoperative triglycerideglucose index as a metabolic predictor of surgical site infection after posterior lumbar fusion Yu Hua, Shaoxing Li, Yuan Jiang, Jinwang Liu Journal of Orthopaedic Surgery.2026;[Epub] CrossRef Development and validation of a risk nomogram model for predicting superficial fungal infections in patients with type 2 diabetes mellitus : a cross-sectional study Yu Li, Guozhong Zhou, Feifei Yang, Rong long, Wei Shi, Yan Dong, Yuanyuan Zhou, Nan Chen, Ying Yang BMC Infectious Diseases.2026;[Epub] CrossRef Transcending risk factors: the implications of redefining diabetes as an immunometabolic disease for infectious disease studies Xiujun Zhang, Fan Zhang, Wenjian Li Frontiers in Immunology.2026;[Epub] CrossRef Atypical Spread of Head and Neck Phlegmon: Case Series Requiring Multidisciplinary Management Monika Warlewska, Daria Wzitek-Kuczmik, Jakub Fiegler-Rudol, Iwona Niedzielska Journal of Maxillofacial and Oral Surgery.2026;[Epub] CrossRef A study on metabolic differences between infectious and non-infectious stones in patients with urine culture positive for Proteus mirabilis Endi Zhang, Zhichao Chi, Xuming Zhang, Jianxing Li, Chaoyue Ji, Weiguo Hu BMC Urology.2026;[Epub] CrossRef Long-Term Hyperglycemia Affects the Expression of Diaph1 and Its Cytoskeleton Ligands in the Epidermis of Diabetic PatientsA Quantitative Study Bernard Kordas, Wojciech Matuszewski, Robert Modzelewski, Jarosaw Szuszkiewicz, Micha Zacki, Joanna Wojtkiewicz, Judyta Juranek Diabetology.2026

You lose fat from everywhere, including subcutaneous depots